Here are 18 things to know about ESD efficacy and safety, according two studies presented at Digestive Disease Week in Chicago.
Long-term outcomes for ESD in colorectal cancer
A group of curative resection patients had outcomes including:
• Three-year recurrence-free survival: 100 percent
• Three-year overall survival: 98 percent
• Five-year recurrence-free survival: 100 percent
• Five-year overall survival: 96.8 percent
A group of patients with non-curative resection and additional surgery patients had outcomes including:
• Three-year recurrence-free survival: 96.2 percent
• Three-year overall survival: 98 percent
• Five-year recurrence-free survival: 96.2 percent
• Five-year overall survival: 98 percent
A group of patients with non-curative resection and no additional surgery had outcomes including:
• Three-year recurrence-free survival: 97.9 percent
• Three-year overall survival: 100 percent
• Five-year recurrence-free survival: 89.5 percent
• Five-year overall survival: 100 percent
Independent predictors of en bloc resection failure or perforation
• Endoscopist: Experienced vs. inexperienced
• Location: Right side vs. rectum and left side vs. rectum
• Macroscopic type: Protruding vs. LST-G
• On semilunar fold: Present vs. absent
• Fold convergence: Present vs. absent
• Scope operability: Poor vs. good
More articles on gastroenterology:
Does IBD up the risk of heavy opioid use?
Breaking down the cost of Hepatitis C treatment: 7 things to know
20 things for gastroenterologists to know about Medicare reimbursement
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
